Tuberculosis Infection Clinical Trial
Official title:
Contact Tracing by Social Network Analysis to Enhance Multi-Drug Resistant Tuberculosis Case Finding in Hanoi, Vietnam
Tuberculosis burden in Vietnam increasing with contribution from low detection rates and
increased drug resistance. There is a need to identify MDR-TB (MultiDrug Resistant
Tuberculosis) among both notified TB cases and their contacts in the community. Traditional
contact tracing often focuses on household contacts while strains of TB circulate in homes,
schools, workplaces, and beyond. Social network Analysis (SNA) is a comprehensive approach
which includes a set of persons and the connections among them used for analysis of
structure of disease transmission.
In this study, SNA will be used to collect network data from 60 newly detected Rifampicin
resistant TB patients including an expected 50 MDR-TB patients living in Hanoi, and to
identify and test potential MDR-TB cases.
The study will identify and recruit 60 newly detected Rifampicin resistant TB patients
including an expected 50 MDR-TB patients living in Hanoi (index cases) who will undergo SNA
of contacts and places they have stayed during 3 months preceding their TB diagnosis
including residence, travel history, places of social aggregation in relation with their
risk behaviour.
Patients will be interviewed to investigate contacts before the confirmation of MDR-TB (for
early contact detection and minimize the risk of information lost due to patient default
during treatment). Data analysis will focus on MDR-TB social networks using Cytoscape
software.
After the first two enrolled Rifampicin resistant MDR-TB cases, social network data will be
analyzed to identify close contacts, mutual contacts, mutual places and high risk locations.
The Social Network Questionnaire (SNQ) will be contextualized to the Vietnamese setting and
validated in a pilot study. Eligible contacts and locations will undergo MDR-TB screening.
Approximately 720 contacts will undergo active screening (on 2 occasions per individual: at
the time of contact identification and 6 months later). Contacts will include household
contacts, close contacts, mutual contacts and symptomatic individuals with significant
exposure to the index case at mutual locations within a closed environment.
Contact screening will involve clinical assessment, chest X-ray and sputum or gastric
aspirate collection for TB culture, molecular techniques and microbiological identification.
If contacts are screened and detected as having Rifampicin resistant TB, they will be
invited to be included in SNA for further analysis.
The number of MDR-TB detected by SNA will determine whether transmission of MDR-TB not
otherwise detected by routine contact investigation (only household contact tracing) is
important. While traditional contact tracing practices in Vietnam mainly focus on household
contacts to detect secondary cases of TB, this SNA is expected not only to identify
secondary cases of MDR-TB within an extended catchment but to also identify the source cases
of MDR-TB patients to " turn off the tap" of MDR-TB transmission. Moreover, the places
identified as the sources of sustained transmission will be targeted for case finding along
with appropriate resource allocation.
In this study analysis will focus on the costs of contact tracing with Social Network
Questionnaires, the proportion of MDR-TB among eligible contacts by subgroup, the proportion
of MDR-TB among Rifampicin resistant TB patients and the genotyping pattern of MDR -TB
patients.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04271397 -
Immunological Biomarkers in Tuberculosis Management
|
N/A | |
Completed |
NCT04545164 -
Computer Aided Screening for Tuberculosis in Low Resource Environments
|
N/A | |
Recruiting |
NCT05766267 -
Short-course Regimens for the Treatment of Pulmonary Tuberculosis
|
Phase 2/Phase 3 | |
Recruiting |
NCT05756582 -
Prevalence of Latent Tuberculosis Infection in Health-care Workers and Students
|
||
Enrolling by invitation |
NCT04988984 -
Development of Automated Molecular Diagnostic Platform for Tuberculosis Diagnosis (New Assay TB)
|
||
Recruiting |
NCT04148053 -
Evaluation of Immune Cell Markers in Diagnosis of Tuberculosis
|
||
Recruiting |
NCT01689831 -
Dose Study of Tuberculin Purified Protein Derivative (JHP/Dose)
|
Phase 2 | |
Completed |
NCT05945498 -
Evaluation of ТВ/Flu-05Е Vaccine for the Prevention of Tuberculosis Infection in BCG-vaccinated Volunteers Aged 18-50 Years
|
Phase 1 | |
Not yet recruiting |
NCT06352970 -
Effects of Tuberculosis Infection on Development and Function of the Placenta
|
||
Recruiting |
NCT04575519 -
Adjunctive Acetylsalicylic Acid and Ibuprofen for Tuberculosis
|
Phase 2 | |
Recruiting |
NCT05413551 -
Point-of-care Pharmacogenomic Testing to Optimize Isoniazid Dosing for Tuberculosis Prevention
|
Phase 1 | |
Recruiting |
NCT03941210 -
Micro RNA as Prediction and/or Prognostic Markers of IRIS in TB-HIV Co-infected Patients
|
||
Completed |
NCT04494516 -
Qualitative Understanding of Community TB Services Pre and Post the CHIP-TB Trial
|
||
Withdrawn |
NCT03265977 -
A Phase II Study of H56:IC31 in Healthy Adolescents
|
Phase 2 | |
Recruiting |
NCT05069688 -
Dolutegravir Pharmacokinetics Among HIV/TB Coinfected Children Receiving Standard and High-dose Rifampicin
|
Phase 1 | |
Suspended |
NCT05330884 -
BCG Revaccination in Children and Adolescents
|
Phase 3 | |
Recruiting |
NCT05342064 -
Closing -TB GAPs - for People Living With HIV: TB Guidance for Adaptable Patient-Centered Service
|
N/A | |
Recruiting |
NCT05236452 -
Effect of Integrating Traditional Tuberculosis Care With Modern Health Care on Case Detection
|
N/A | |
Recruiting |
NCT05443178 -
Safety and Tolerability of Chlorquine in Addition to Anti-tuberculosis Therapy
|
Phase 1 | |
Recruiting |
NCT05122026 -
Safety and Tolerability of 1 Month Daily (1HP) and 3 Months Weekly (3HP) Isoniazid and Rifapentine With Pharmacokinetics of Dolutegravir (DTG) in Pregnant People With HIV
|
Phase 1/Phase 2 |